aspirin and clopidogrel

DRUG8 trials

Conditions

Atrial FibrillationCarotid Artery InjuryCoronary Artery DiseaseCoronary DiseaseEmbolic StrokeHealthy VolunteersLeft Atrial Appendage ClosureLeft Atrial Appendage Occlusion

Phase 3

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

Active, not recruitingNCT04946734

Guangdong Provincial People's HospitalMigraine, PFO - Patent Foramen Ovale

Start: 2021-08-12End: 2025-09-06Target: 440Updated: 2025-03-12

Phase 4

Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation

CompletedNCT00822536

Assistance Publique - Hôpitaux de ParisCoronary Artery Disease, Myocardial Ischemia, Stent Thrombosis

Start: 2009-01-31End: 2014-09-30Updated: 2014-10-17

Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling

NCT02224131

Beijing Tiantan HospitalEmbolic Stroke

Start: 2015-01-31End: 2020-12-31Target: 1856Updated: 2014-08-25

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events

CompletedNCT02939872

Seung-Jung ParkCoronary Disease, Percutaneous Transluminal Coronary Angioplasty

Start: 2017-03-09End: 2024-06-03Updated: 2024-06-25

A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

NCT03088072

Scripps HealthLeft Atrial Appendage Closure, Non-Valvular Atrial Fibrillation

Start: 2017-03-23End: 2019-12-31Target: 75Updated: 2017-07-11

Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

NCT05671276

The First Affiliated Hospital with Nanjing Medical UniversityAtrial Fibrillation, Left Atrial Appendage Occlusion, Silent Cerebral Embolism

Start: 2022-02-01End: 2024-09-01Target: 150Updated: 2023-01-04

Unknown Phase

Anticoagulation in Blunt Cerebrovascular Injuries

WithdrawnNCT00494156

C. Clay Cothren, MDCarotid Artery Injury, Vertebral Artery Injury

Start: 2003-07-31End: 2008-07-31Updated: 2015-10-21

Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma

NCT01264640

University of RostockHealthy Volunteers

Start: 2010-07-31End: 2011-03-31Target: 25Updated: 2010-12-22

Related Papers

Half-Dose Anticoagulation versus Antiplatelet Therapy to Reduce Silent Cerebral Embolism after Left Atrial Appendage Occlusion (HALO-SCE Study): Rationale and Design of a Randomized Clinical Trial

Cerebrovascular Diseases2025-07-15

Rationale and design of the SPRING trail: effectivity and safety of Pfo closuRe vs medIcine in alleviatiNg migraine, a multicenter, randomized and open-label trail

BMC Cardiovascular Disorders2024-04-05

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial

European Heart Journal2015-09-12175 citations

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial.

2013-02-2111 citations